drugset / Trial / NCT04449250
Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 25 mg trimodal tablets in healthy adult volunteers.
Timeline
- Start
- 2022-09-14
- Primary completion
- 2022-10-14
- Completion
- 2022-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | dexmethylphenidate | Unknown | 25 mg | — |
Indications
No indication recorded.